Unmet potential of Generics and Biosimilars to reduce healthcare costs
Pricing of oral generic cancer medicines in 25 European countries; findings and implications
Are there biosimilar orphan drugs for Gaucher disease? An overview in Mexico
2nd MENA Stakeholder Meeting on Biosimilars 2018 – Report
Escalating prices of generic drugs targeted by US anti-gouging legislation
Source URL: http://gabi-journal.net/2019-2-gabi-journal-table-of-contents.html
Copyright ©2020 GaBI Journal unless otherwise noted.